Biomedical Engineering

Updated: over 2 years ago
Location: Silver Spring, MARYLAND
Deadline: The position may have been removed or expired!

Position Description:

*Applications will be reviewed on a rolling-basis.

A research opportunity is currently available in the Office of Tissues and Advanced Therapies (OTAT) at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.

CBER’s mission is to ensure the safety, purity, potency, and effectiveness of biological products including vaccines, blood and blood products, and cells, tissues, and gene therapies for the prevention, diagnosis, and treatment of human diseases, conditions, or injury. The selected participant will have the opportunity to learn how biomedical engineering approaches such as microphysiological systems and biomaterials would be used in the assessment of cellular and tissue engineered products. The project will employ a variety of approaches including microfluidics, biomaterials engineering, high-resolution imaging, and molecular biology.

Anticipated Appointment Start Date: September 2021; start date is flexible

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.


Qualifications:

The qualified candidate should have received a doctoral degree in one of the relevant fields, or be currently pursuing the degree with completion by the appointment start date. Degree must have been received within the past five years.

Preferred skills:


  • Experience in microfluidics, 3D in vitro system, cell and molecular biology
  • Understanding of high-throughput screening, immunology, and tissue engineering
  • Experience in various imaging technologies and molecular biology technologies

To Apply:

A complete application consists of:


  • An application
  • Transcript(s) – For this opportunity, an unofficial transcript or copy of the student academic records printed by the applicant or by academic advisors from internal institution systems may be submitted. All transcripts must be in English or include an official English translation. Click here for detailed information about acceptable transcripts.
  • A current resume/CV, including academic history, employment history, relevant experiences, and publication list
  • One educational or professional recommendation

All documents must be in English or include an official English translation.


If you have questions, send an email to

[email protected]

. Please include the reference code for this opportunity (FDA-CBER-2021-0036) in your email.


Application Deadline: September 6, 2021 3:00PM EST



Similar Positions